Home » Stocks » LBPH

Longboard Pharmaceuticals, Inc. (LBPH)

Longboard Pharmaceuticals will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) -1.40M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Hide News
NASDAQ - 1 week ago

Longboard Pharmaceuticals, a phase 1 biotech formed by Arena Pharmaceuticals developing medicines for neurological diseases, filed on Friday with the SEC to raise up to $86 million in an initi...

SEC - 1 week ago

Longboard Pharmaceuticals, Inc. has filed to go public with an IPO on the NASDAQ.

About LBPH

Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. We were formed in January 2020 by Arena Pharmaceuticals, Inc. (Arena) to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). Our small molecule product candidates were discovered out of the same platform at Arena that represents a culmination of more than 20 years of GPCR research. We are developing LP352,... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Pending
CEO
Kevin R. Lind
Employees
6
Stock Exchange
NASDAQ
Ticker Symbol
LBPH
Full Company Profile